glp-1 gip medication long term effects muscle loss The Role of GLP-1RA Medications in Medical Weight and the Positive Impacts on Lipid Management | Current Cardiovascular Risk Reports Glucagon-like peptide-1 receptor agonists and

These medications are clinically proven, require prescriptions, and are regulated to ensure patient safety

KFF Health Tracking Poll May 2024: The publics use and views of GLP-1 drugs

Focus on nutrient-dense foods including lean proteins, whole grains, fruits, and vegetables

Semaglutide (marketed as Wegovy for weight management and Ozempic for diabetes) produced an average 15.8% body weight reduction over 68 weeks in the STEP trials

Abstract Atherosclerosis is a chronic metabolic disorder driven by endothelial dysfunction, inflammation, oxidative stress, and progressive plaque remodeling

It works by increasing insulin production, lowering glucagon secretion, and targeting appetite-regulating centers in the brain